Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Mutagrip in Elderly and SOT Recipients
NCT02746783Phase 2Completed
- Sponsor
- Lausanne University Hospital
- Start
- Oct 2013
- Primary completion
- Jul 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Mutagrip in influenza (2 arms), sponsored by Lausanne University Hospital. Primary endpoint: Change from Baseline in Immunogenicity at 24 weeks. Started Oct 2013; status: completed.
02
Drugs
Mutagrip
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02746783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02746783.